TLR4 and Myocardial fibrosis: Emerging research has consistently shown that Galectin-3 mediates fibrosis, exemplified by inhibiting Galectin-3 that reduces the inflammatory activation of TLR4 and downstream NF-κB to prevent myocardial fibrosis [38].